首页 | 本学科首页   官方微博 | 高级检索  
     


The impact of inhaled corticosteroid and long-acting β-agonist combination therapy on outcomes in COPD
Authors:Nicola A. Hanania  
Affiliation:aSection of Pulmonary and Critical Care Medicine, Asthma Clinical Research Center, Baylor College of Medicine, 1504 Taub Loop, Houston, TX 77030, USA
Abstract:
Keywords:Budesonide   Chronic obstructive pulmonary disease   Corticosteroids   Fluticasone propionate   Formoterol   Inhaled corticosteroid   Long-acting β  2-Agonist   Mortality   Salmeterol
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号